Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 3/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | NFE2L2 | Q16236 | 5/20 | 0.42 |
| ▸ | PGR | P06401 | 2/20 | 0.42 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | HTR6 | P50406 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29415251 | 0.84 | HTR6 (0.43) | KDM4ECYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL777664 | 0.84 | HTR6 (0.43) | KDM4ECYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL13290758 | 0.83 | MCOLN3 (0.49) | PGRTSHRKMT2AMCOLN3CCR4 | |
| SCHEMBL8634554 | 0.82 | HSD11B1 (0.46) | HSD11B1KDM4ECYP1A2CYP3A4CYP2D6 | |
| SCHEMBL13290726 | 0.82 | HSD11B1 (0.46) | HSD11B1NFE2L2KCNH2ALDH1A1HTR6 | |
| SCHEMBL15352788 | 0.80 | CCR4 (0.46) | MCOLN3CCR4 | |
| SCHEMBL16467788 | 0.80 | CYP1A2 (0.48) | KDM4ECYP1A2CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL8144032 | 0.80 | HSD11B1 (0.43) | HSD11B1KDM4ECYP1A2CYP3A4CYP2D6 | |
| SCHEMBL8712194 | 0.79 | HSD11B1 (0.43) | HSD11B1KDM4ECYP1A2CYP3A4CYP2D6 | |
| SCHEMBL8854485 | 0.79 | HSD11B1 (0.40) | HSD11B1KDM4ECYP1A2CYP3A4CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112759575-B | Preparation method of clopidogrel hydrogen sulfate and intermediate N- (2-thienylethyl) methylamine thereof | 武汉武药制药有限公司 | 2022-06-07 | — | — | CN | disclosed |
| CN-112759575-A | Preparation method of clopidogrel hydrogen sulfate and intermediate N- (2-thienylethyl) methylene thereof | 武汉武药制药有限公司 | 2021-05-07 | — | — | CN | disclosed |
| EP-2841429-B1 | TETRAZOLINONE COMPOUNDS AND ITS USE AS PESTICIDES | SUMITOMO CHEMICAL CO (JP) | 2020-10-21 | — | — | EP | disclosed |
| US-9565856-B2 | Tetrazolinone compounds and its use as pesticides | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-02-14 | — | — | US | disclosed |
| EP-2841429-A1 | TETRAZOLINONE COMPOUNDS AND ITS USE AS PESTICIDES | Sumitomo Chemical Company Limited (JP) | 2015-03-04 | — | — | EP | disclosed |
| US-20150051171-A1 | TETRAZOLINONE COMPOUNDS AND ITS USE AS PESTICIDES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2015-02-19 | — | — | US | disclosed |
| CN-102361837-B | Process for producing conjugated aromatic compound | SUMITOMO CHEMICAL CO | 2014-07-02 | — | — | CN | disclosed |
| WO-2013162072-A1 | TETRAZOLINONE COMPOUNDS AND ITS USE AS PESTICIDES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-10-31 | — | — | WO | disclosed |
| US-8293905-B2 | Bipyridine compound, transition metal complex, and method for production of conjugated aromatic compound using the transition metal complex | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-10-23 | — | — | US | disclosed |
| CN-102361837-A | Process for producing conjugated aromatic compound | SUMITOMO CHEMICAL CO | 2012-02-22 | — | — | CN | disclosed |
| US-5922896-A | Process for making O,S-dimethyl phosphoramidothioate | BAYER CORPORATION (US) | 1999-07-13 | — | — | US | disclosed |
| US-5717124-A | Process for preparation of oxyglutaric acid ester derivatives | UBE INDUSTRIES, LTD. (JP) | 1998-02-10 | — | — | US | disclosed |
| EP-0239784-B1 | CURABLE COMPOSITIONS CONTAINING A POLYEPOXIDE AND A HALOGENATED BISPHENOL | THE DOW CHEMICAL COMPANY (US) | 1992-05-06 | — | — | EP | disclosed |
| EP-0205455-B1 | CURABLE COMPOSITIONS CONTAINING A POLYEPOXIDE AND A HALOGENATED DIHYDRIC PHENOL AND IMPREGNATED SUBSTRATES AND LAMINATES PREPARED THEREFROM | THE DOW CHEMICAL COMPANY (US) | 1991-03-13 | — | — | EP | disclosed |
| US-4783363-A | ELECTRICAL LAMINATES | THE DOW CHEMICAL COMPANY (US) | 1988-11-08 | — | — | US | disclosed |
| EP-0205455-A4 | CURABLE COMPOSITIONS CONTAINING A POLYEPOXIDE AND A HALOGENATED DIHYDRIC PHENOL AND IMPREGNATED SUBSTRATES AND LAMINATES PREPARED THEREFROM. | DOW CHEMICAL CO (US) | 1988-04-26 | — | — | EP | disclosed |
| EP-0239784-A2 | Curable compositions containing a polyepoxide and a halogenated bisphenol | THE DOW CHEMICAL COMPANY (US) | 1987-10-07 | — | — | EP | disclosed |
| EP-0205455-A1 | CURABLE COMPOSITIONS CONTAINING A POLYEPOXIDE AND A HALOGENATED DIHYDRIC PHENOL AND IMPREGNATED SUBSTRATES AND LAMINATES PREPARED THEREFROM. | DOW CHEMICAL CO (US) | 1986-12-30 | — | — | EP | disclosed |
| US-4604317-A | ELECTRICAL LAMINATES | THE DOW CHEMICAL COMPANY (US) | 1986-08-05 | — | — | US | disclosed |
| WO-1986002085-A1 | CURABLE COMPOSITIONS CONTAINING A POLYEPOXIDE AND A HALOGENATED DIHYDRIC PHENOL AND IMPREGNATED SUBSTRATES AND LAMINATES PREPARED THEREFROM | THE DOW CHEMICAL COMPANY (US) | 1986-04-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150051171-A1 | TETRAZOLINONE COMPOUNDS AND ITS USE AS PESTICIDES | CBR3, CYCS, CBR1 | HSD11B1 585/4885KDM4E 3020/4885CYP1A2 49/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.